{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:38:24Z","timestamp":1791938304026,"version":"4.3.4"},"reference-count":225,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.addr.2023.114960","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:45:34Z","timestamp":1686401134000},"page":"114960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"special_numbering":"C","title":["Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies"],"prefix":"10.1016","volume":"199","author":[{"given":"Hui","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Whiteway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.114960_b0005","doi-asserted-by":"crossref","unstructured":"G.D. Brown D.W. Denning N.A. Gow S.M. Levitz M.G. Netea T.C. White Hidden killers: human fungal infections Sci. Transl. Med. 4 (2012) 165rv113.","DOI":"10.1126\/scitranslmed.3004404"},{"key":"10.1016\/j.addr.2023.114960_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.671068","article-title":"Vaccine-induced immunological memory in invasive fungal infections - a Dream so Close yet so Far","volume":"12","author":"Biswas","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0015","doi-asserted-by":"crossref","unstructured":"M.C. Arendrup, B. Bruun, J.J. Christensen, K. Fuursted, H.K. Johansen, P. Kjaeldgaard, J.D. Knudsen, L. Kristensen, J. M\u00f8ller, L. Nielsen, F.S. Rosenvinge, B. R\u00f8der, H.C. Sch\u00f8nheyder, M.K. Thomsen, K. Truberg, National surveillance of fungemia in Denmark (2004 to 2009), J. Clin. Microbiol., 49 (2011) 325-334.","DOI":"10.1128\/JCM.01811-10"},{"key":"10.1016\/j.addr.2023.114960_b0020","doi-asserted-by":"crossref","first-page":"myac071","DOI":"10.1093\/mmy\/myac071","article-title":"Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010\u20132019: A retrospective observational study based on national surveillance data","volume":"60","author":"Kajihara","year":"2022","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114960_b0025","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001459","article-title":"Antifungal susceptibility profile of invasive Candida glabrata isolates (2009\u20132020) from a tertiary care hospital laboratory in Pakistan","volume":"70","author":"Memon","year":"2021","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.addr.2023.114960_b0030","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1080\/22221751.2021.1944323","article-title":"Clade distribution of Candida auris in South Africa using whole genome sequencing of clinical and environmental isolates","volume":"10","author":"Naicker","year":"2021","journal-title":"Emerg. Microbes. Infect."},{"key":"10.1016\/j.addr.2023.114960_b0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/jof8080787","article-title":"Emergence and Genomic Characterization of Multidrug Resistant Candida auris in Nigeria, West Africa","volume":"8","author":"Oladele","year":"2022","journal-title":"J. Fungi. (Basel)"},{"key":"10.1016\/j.addr.2023.114960_b0040","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/CCM.0b013e318206c1ca","article-title":"Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study","volume":"39","author":"Kett","year":"2011","journal-title":"Crit. Care. Med"},{"key":"10.1016\/j.addr.2023.114960_b0045","doi-asserted-by":"crossref","unstructured":"P.E.A. Mohd Badri, N.A.R. Rismayuddin, N.M. Kenali, D.S. Darnis, M.H. Arzmi, Characterization of Cervus timorensis velvet antler and its effect on biofilm formation of Candida species, Med. Mycol. 60 (2022) myac073.","DOI":"10.1093\/mmy\/myac073"},{"key":"10.1016\/j.addr.2023.114960_b0050","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3390\/jof8090921","article-title":"Sensitivity of Serum Beta-D-Glucan in Candidemia According to Candida Species Epidemiology in Critically Ill Patients Admitted to the Intensive Care Unit","volume":"8","author":"Mikulska","year":"2022","journal-title":"J. Fungi. (Basel)"},{"key":"10.1016\/j.addr.2023.114960_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.33073\/pjm-2022-036","article-title":"Opportunistic Candida Infections in Critical COVID-19 Patients","volume":"71","author":"Altinkaya \u00c7avu\u015f","year":"2022","journal-title":"Pol. J. Microbiol."},{"key":"10.1016\/j.addr.2023.114960_b0060","article-title":"Fungal colonization and infections in patients with COVID-19 in intensive care units: A real-life experience at a tertiary-care hospital","volume":"82","author":"Avkan-O\u011fuz","year":"2022","journal-title":"Respir. Med. Res"},{"key":"10.1016\/j.addr.2023.114960_b0065","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2023.114960_b0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev-micro-030117-020345","article-title":"Molecular Evolution of Antifungal Drug Resistance","volume":"71","author":"Robbins","year":"2017","journal-title":"Annu. Rev. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/fmb.11.19","article-title":"Current perspectives on echinocandin class drugs","volume":"6","author":"Perlin","year":"2011","journal-title":"Future. Microbiol"},{"issue":"2016","key":"10.1016\/j.addr.2023.114960_b0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dkz400","article-title":"Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans","volume":"75","author":"Nishimoto","year":"2020","journal-title":"J. Antimicrob. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrmicro2711","article-title":"Candida albicans morphogenesis and host defence: discriminating invasion from colonization","volume":"10","author":"Gow","year":"2011","journal-title":"Nat. Rev. Microbiol"},{"issue":"Suppl 4","key":"10.1016\/j.addr.2023.114960_b0100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2008.01606.x","article-title":"Epidemiological trends in skin mycoses worldwide","volume":"51","author":"Havlickova","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114960_b0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.it.2016.04.007","article-title":"Skin Immunity to Candida albicans","volume":"37","author":"Kashem","year":"2016","journal-title":"Trends. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0110","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nrm1619","article-title":"The cornified envelope: a model of cell death in the skin","volume":"6","author":"Candi","year":"2005","journal-title":"Nat. Rev. Mol. Cell. Biol"},{"key":"10.1016\/j.addr.2023.114960_b0115","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/hmg\/ddr494","article-title":"Loss of ceramide synthase 3 causes lethal skin barrier disruption","volume":"21","author":"Jennemann","year":"2012","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.addr.2023.114960_b0120","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1172\/JCI27114","article-title":"Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors","volume":"116","author":"Netea","year":"2006","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.addr.2023.114960_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ni1408","article-title":"Dectin-1 is required for beta-glucan recognition and control of fungal infection","volume":"8","author":"Taylor","year":"2007","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jdermsci.2010.11.009","article-title":"The expression of \u03b2-defensin-2, 3 and LL-37 induced by Candida albicans phospholipomannan in human keratinocytes","volume":"61","author":"Li","year":"2011","journal-title":"J. Dermatol. Sci"},{"key":"10.1016\/j.addr.2023.114960_b0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","article-title":"Toll-like receptors in skin","volume":"24","author":"Miller","year":"2008","journal-title":"Adv. Dermatol"},{"key":"10.1016\/j.addr.2023.114960_b0140","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.3390\/ijms21186791","article-title":"Psoriasis and Antimicrobial Peptides","volume":"21","author":"Takahashi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.114960_b0145","first-page":"496","article-title":"The synergistic activities of the combination of tumour necrosis factor-\u03b1, interleukin-17A and interferon-\u03b3 in epidermal keratinocytes","volume":"179","author":"Morizane","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2023.114960_b0150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2016.06.038","article-title":"\u03b2-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis","volume":"139","author":"Kolbinger","year":"2017","journal-title":"J. Allergy. Clin. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0155","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4049\/jimmunol.175.3.1776","article-title":"The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes","volume":"175","author":"Niyonsaba","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0160","article-title":"Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris","volume":"8","author":"Rather","year":"2022","journal-title":"J. Fungi. (Basel)"},{"key":"10.1016\/j.addr.2023.114960_b0165","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.3390\/ijms221910633","article-title":"Candida albicans Sfp1 Is Involved in the Cell Wall and Endoplasmic Reticulum Stress Responses Induced by Human Antimicrobial Peptide LL-37","volume":"22","author":"Hsu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2023.114960_b0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/mmy\/myu026","article-title":"Melanocytes and melanin represent a first line of innate immunity against Candida albicans","volume":"52","author":"Tapia","year":"2014","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114960_b0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/jtbi.2001.2331","article-title":"The antimicrobial properties of melanocytes, melanosomes and melanin and the evolution of black skin","volume":"211","author":"Mackintosh","year":"2001","journal-title":"J. Theor. Biol"},{"key":"10.1016\/j.addr.2023.114960_b0180","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-neuro-111020-105359","article-title":"Neuroimmune Interactions in Peripheral Organs","volume":"45","author":"Klein Wolterink","year":"2022","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.addr.2023.114960_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation","volume":"510","author":"Riol-Blanco","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.114960_b0190","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/jid.2012.464","article-title":"Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model","volume":"133","author":"Roggenkamp","year":"2013","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.addr.2023.114960_b0195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2015.08.016","article-title":"Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity","volume":"43","author":"Kashem","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2023.114960_b0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.isci.2018.08.007","article-title":"The ATP Transporter VNUT Mediates Induction of Dectin-1-Triggered Candida Nociception","volume":"6","author":"Maruyama","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.addr.2023.114960_b0205","doi-asserted-by":"crossref","unstructured":"J.A. Cohen T.N. Edwards A.W. Liu T. Hirai M.R. Jones J. Wu Y. Li S. Zhang J. Ho B.M. Davis K.M. Albers D.H. Kaplan Cutaneous TRPV1(+) Neurons Trigger Protective Innate Type 17 Anticipatory Immunity Cell 178 (2019) 919 932 e914.","DOI":"10.1016\/j.cell.2019.06.022"},{"key":"10.1016\/j.addr.2023.114960_b0210","doi-asserted-by":"crossref","unstructured":"F.A. Pinho-Ribeiro B. Baddal R. Haarsma M. O'Seaghdha N.J. Yang K.J. Blake M. Portley W.A. Verri J.B. Dale M.R. Wessels I.M. Chiu Blocking Neuronal Signaling to Immune Cells Treats Streptococcal Invasive Infection Cell 173 (2018) 1083 1097 e1022.","DOI":"10.1016\/j.cell.2018.04.006"},{"key":"10.1016\/j.addr.2023.114960_b0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2008.05.014","article-title":"Antimicrobial activity of neuropeptides against a range of micro-organisms from skin, oral, respiratory and gastrointestinal tract sites","volume":"200","author":"El Karim","year":"2008","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.addr.2023.114960_b0220","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.cell.2021.03.002","article-title":"Nonpeptidergic neurons suppress mast cells via glutamate to maintain skin homeostasis","volume":"184","author":"Zhang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.addr.2023.114960_b0225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jid.2021.10.006","article-title":"Neuron-Mast Cell Cross-Talk in the Skin","volume":"142","author":"Zhang","year":"2022","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.addr.2023.114960_b0230","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1152\/jn.01396.2007","article-title":"Cutaneous sensory neurons expressing the Mrgprd receptor sense extracellular ATP and are putative nociceptors","volume":"99","author":"Dussor","year":"2008","journal-title":"J. Neurophysiol"},{"key":"10.1016\/j.addr.2023.114960_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.3881","article-title":"Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing","volume":"18","author":"Usoskin","year":"2015","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.addr.2023.114960_b0240","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jid.2021.03.010","article-title":"ATP released by Candida albicans is associated with reduced skin infectivity","author":"Zhang","year":"2021","journal-title":"J. Invest. Dermatol141"},{"key":"10.1016\/j.addr.2023.114960_b0245","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-051116-052215","article-title":"Antigen-Presenting Cells in the Skin","volume":"35","author":"Kashem","year":"2017","journal-title":"Annu. Rev. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.immuni.2011.06.005","article-title":"Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses","volume":"35","author":"Igyarto","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2023.114960_b0255","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.4049\/jimmunol.1102759","article-title":"Langerhans cells require MyD88-dependent signals for Candida albicans response but not for contact hypersensitivity or migration","volume":"188","author":"Haley","year":"2012","journal-title":"J. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0260","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.immuni.2015.01.008","article-title":"Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation","volume":"42","author":"Kashem","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2023.114960_b0265","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/imm.12562","article-title":"Transient receptor potential vanilloid 1 expression and function in splenic dendritic cells: a potential role in immune homeostasis","volume":"147","author":"Assas","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2023.114960_b0270","doi-asserted-by":"crossref","first-page":"eaan2725","DOI":"10.1126\/sciimmunol.aan2725","article-title":"Skin infections are eliminated by cooperation of the fibrinolytic and innate immune systems","volume":"2","author":"Santus","year":"2017","journal-title":"Sci. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0275","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.4049\/jimmunol.1302265","article-title":"Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis","volume":"192","author":"Huppler","year":"2014","journal-title":"J. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0280","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"Liang","year":"2006","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.addr.2023.114960_b0285","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0290","doi-asserted-by":"crossref","first-page":"e0122807","DOI":"10.1371\/journal.pone.0122807","article-title":"Signaling through IL-17C\/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis","volume":"10","author":"Conti","year":"2015","journal-title":"PLoS. One"},{"key":"10.1016\/j.addr.2023.114960_b0295","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/eji.201242569","article-title":"IL-17-producing \u03b3\u03b4 T cells and innate lymphoid cells","volume":"42","author":"Sutton","year":"2012","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0300","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jaci.2017.09.042","article-title":"Staged development of long-lived T-cell receptor \u03b1\u03b2 T(H)17 resident memory T-cell population to Candida albicans after skin infection","volume":"142","author":"Park","year":"2018","journal-title":"J. Allergy. Clin. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0305","doi-asserted-by":"crossref","first-page":"eabq3254","DOI":"10.1126\/sciimmunol.abq3254","article-title":"Local IL-23 is required for proliferation and retention of skin-resident memory T(H)17 cells","volume":"7","author":"Whitley","year":"2022","journal-title":"Sci. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0315","doi-asserted-by":"crossref","unstructured":"H. Linley, A. Ogden, S. Jaigirdar, L. Buckingham, J. Cox, M. Priestley, A. Saunders, CD200R1 promotes IL-17 production by ILC3s, by enhancing STAT3 activation, bioRxiv, (2022) 2022.2004.2017.488595.","DOI":"10.1101\/2022.04.17.488595"},{"key":"10.1016\/j.addr.2023.114960_b0320","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis\u2013results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.addr.2023.114960_b0325","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.addr.2023.114960_b0330","doi-asserted-by":"crossref","unstructured":"M. Lebwohl, B. Strober, A. Menter, K. Gordon, J. Weglowska, L. Puig, K. Papp, L. Spelman, D. Toth, F. Kerdel, A.W. Armstrong, G. Stingl, A.B. Kimball, H. Bachelez, J.J. Wu, J. Crowley, R.G. Langley, T. Blicharski, C. Paul, J.P. Lacour, S. Tyring, L. Kircik, S. Chimenti, K. Callis Duffin, J. Bagel, J. Koo, G. Aras, J. Li, W. Song, C.E. Milmont, Y. Shi, N. Erondu, P. Klekotka, B. Kotzin, A. Nirula, Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis, N Engl J Med, 373 (2015) 1318-1328.","DOI":"10.1056\/NEJMoa1503824"},{"key":"10.1016\/j.addr.2023.114960_b0335","article-title":"Risk of candidiasis associated with interleukin-17 inhibitors: A real-world observational study of multiple independent sources","volume":"13","author":"Davidson","year":"2022","journal-title":"Lancet. Reg. Health. Eur"},{"key":"10.1016\/j.addr.2023.114960_b0340","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/imr.12454","article-title":"How neutrophils kill fungi","volume":"273","author":"Gazendam","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2023.114960_b0345","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3390\/cells10102736","article-title":"Proteinous Components of Neutrophil Extracellular Traps Are Arrested by the Cell Wall Proteins of Candida albicans during Fungal Infection, and Can Be Used in the Host Invasion","volume":"10","author":"Karkowska-Kuleta","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.addr.2023.114960_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102871","article-title":"Neutrophils require SKAP2 for reactive oxygen species production following C-type lectin and Candida stimulation","volume":"24","author":"Nguyen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.addr.2023.114960_b0355","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/cells11020236","article-title":"S100A8\/A9 Is a Marker for the Release of Neutrophil Extracellular Traps and Induces Neutrophil Activation","volume":"11","author":"Sprenkeler","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.addr.2023.114960_b0360","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13693780500057551","article-title":"Influence of endogenous pro-inflammatory cytokines on neutrophil-mediated damage of Candida albicans pseudohyphae, quantified in a modified tetrazolium dye assay","volume":"43","author":"Vonk","year":"2005","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114960_b0365","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0370","doi-asserted-by":"crossref","first-page":"16465","DOI":"10.1073\/pnas.2003022117","article-title":"Immunity to commensal skin fungi promotes psoriasiform skin inflammation","volume":"117","author":"Hurabielle","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.addr.2023.114960_b0375","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin. Microbiol. Rev"},{"key":"10.1016\/j.addr.2023.114960_b0380","doi-asserted-by":"crossref","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.addr.2023.114960_b0385","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/JLB.4HI1221-722R","article-title":"Transfusable neutrophil progenitors as cellular therapy for the prevention of invasive fungal infections","volume":"111","author":"Sykes","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2023.114960_b0390","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41409-022-01827-y","article-title":"Infectious complications after second allogeneic hematopoietic cell transplant in adult patients with hematological malignancies, Bone","volume":"57","author":"Maurer","year":"2022","journal-title":"Marrow. Transplant."},{"key":"10.1016\/j.addr.2023.114960_b0395","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000321157","article-title":"Organ-specific innate immune responses in a mouse model of invasive candidiasis","volume":"3","author":"Lionakis","year":"2011","journal-title":"J. Innate. Immun."},{"key":"10.1016\/j.addr.2023.114960_b0400","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/infdis\/jit534","article-title":"Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-\u03b3 produced in part by iNKT cells","volume":"209","author":"Tarumoto","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2023.114960_b0405","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/cmi.12443","article-title":"Neutrophil activation by Candida glabrata but not Candida albicans promotes fungal uptake by monocytes","volume":"17","author":"Duggan","year":"2015","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2023.114960_b0410","doi-asserted-by":"crossref","first-page":"e1010873","DOI":"10.1371\/journal.ppat.1010873","article-title":"Progranulin aggravates lethal Candida albicans sepsis by regulating inflammatory response and antifungal immunity","volume":"18","author":"Liu","year":"2022","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.addr.2023.114960_b0415","doi-asserted-by":"crossref","first-page":"eaay5691","DOI":"10.1126\/scitranslmed.aay5691","article-title":"Restoring glucose uptake rescues neutrophil dysfunction and protects against systemic fungal infection in mouse models of kidney disease","volume":"12","author":"Jawale","year":"2020","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.addr.2023.114960_b0420","first-page":"1029","article-title":"The histopathology of Candida albicans invasion in neonatal rat tissues and in the human blood-brain barrier in culture revealed by light, scanning, transmission and immunoelectron microscopy","volume":"21","author":"Lossinsky","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.addr.2023.114960_b0425","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1038\/s41467-018-06607-1","article-title":"The fungal peptide toxin Candidalysin activates the NLRP3 inflammasome and causes cytolysis in mononuclear phagocytes","volume":"9","author":"Kasper","year":"2018","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b0430","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature17625","article-title":"Candidalysin is a fungal peptide toxin critical for mucosal infection","volume":"532","author":"Moyes","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.114960_b0435","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41590-019-0377-2","article-title":"CARD9(+) microglia promote antifungal immunity via IL-1\u03b2- and CXCL1-mediated neutrophil recruitment","volume":"20","author":"Drummond","year":"2019","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0440","doi-asserted-by":"crossref","first-page":"e1005293","DOI":"10.1371\/journal.ppat.1005293","article-title":"CARD9-Dependent Neutrophil Recruitment Protects against Fungal Invasion of the Central Nervous System","volume":"11","author":"Drummond","year":"2015","journal-title":"PLoS. Pathog"},{"key":"10.1016\/j.addr.2023.114960_b0445","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3389\/fimmu.2017.01798","article-title":"Tissue-Resident Macrophages in Fungal Infections","volume":"8","author":"Xu","year":"2017","journal-title":"Front. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0450","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fcimb.2020.00034","article-title":"Monocytes and the Host Response to Fungal Pathogens","volume":"10","author":"Heung","year":"2020","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2021.04.005","article-title":"Local antifungal immunity in the kidney in disseminated candidiasis","volume":"62","author":"Jawale","year":"2021","journal-title":"Curr. Opin. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0460","doi-asserted-by":"crossref","first-page":"e01204","DOI":"10.1128\/mBio.01204-18","article-title":"A Genome-Wide Screen of Deletion Mutants in the Filamentous Saccharomyces cerevisiae Background Identifies Ergosterol as a Direct Trigger of Macrophage Pyroptosis","volume":"9","author":"Koselny","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.addr.2023.114960_b0465","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.4134","article-title":"Inhibition of CBLB protects from lethal Candida albicans sepsis","volume":"22","author":"Wirnsberger","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2023.114960_b0470","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm.4260","article-title":"JNK1 negatively controls antifungal innate immunity by suppressing CD23 expression","volume":"23","author":"Zhao","year":"2017","journal-title":"Nat. Med"},{"key":"10.1016\/j.addr.2023.114960_b0475","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1038\/s41467-021-27034-9","article-title":"Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages","volume":"12","author":"Ding","year":"2021","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b0480","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020484118","article-title":"Immune cells fold and damage fungal hyphae","volume":"118","author":"Bain","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.addr.2023.114960_b0485","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.chom.2020.09.004","article-title":"Lysosome Fusion Maintains Phagosome Integrity during Fungal Infection","volume":"28","author":"Westman","year":"2020","journal-title":"Cell. Host. Microbe"},{"key":"10.1016\/j.addr.2023.114960_b0490","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110550","article-title":"Immune defence to invasive fungal infections: A comprehensive review","volume":"130","author":"Pathakumari","year":"2020","journal-title":"Biomed. Pharmacother"},{"key":"10.1016\/j.addr.2023.114960_b0500","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.immuni.2013.05.010","article-title":"Interferon-\u03b2 production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans","volume":"38","author":"del Fresno","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2023.114960_b0505","doi-asserted-by":"crossref","first-page":"e1004276","DOI":"10.1371\/journal.ppat.1004276","article-title":"Syk signaling in dendritic cells orchestrates innate resistance to systemic fungal infection","volume":"10","author":"Whitney","year":"2014","journal-title":"PLoS. Pathog"},{"key":"10.1016\/j.addr.2023.114960_b0510","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2014.60.5121","article-title":"Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Prevention and Treatment of Invasive Fungal Disease in Recipients of Allogeneic Stem-Cell Transplantation: A Prospective Multicenter Randomized Phase IV Trial","volume":"33","author":"Wan","year":"2015","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.addr.2023.114960_b0515","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/imt-2016-0141","article-title":"Recent progress in GM-CSF-based cancer immunotherapy","volume":"9","author":"Yan","year":"2017","journal-title":"Immunotherapy"},{"key":"10.1016\/j.addr.2023.114960_b0520","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCRESAHA.117.310960","article-title":"The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice","volume":"121","author":"Haddad","year":"2017","journal-title":"Circ. Res"},{"key":"10.1016\/j.addr.2023.114960_b0525","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1126\/science.aan8423","article-title":"DNGR-1 in dendritic cells limits tissue damage by dampening neutrophil recruitment","volume":"362","author":"Del Fresno","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.114960_b0530","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/21505594.2015.1004977","article-title":"Adaptive immune responses to Candida albicans infection","volume":"6","author":"Richardson","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.addr.2023.114960_b0535","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2019.11.007","article-title":"T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors","volume":"41","author":"Speakman","year":"2020","journal-title":"Trends. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0540","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chom.2012.04.008","article-title":"Th17 cells in immunity to Candida albicans","volume":"11","author":"Hern\u00e1ndez-Santos","year":"2012","journal-title":"Cell. Host. Microbe"},{"key":"10.1016\/j.addr.2023.114960_b0545","doi-asserted-by":"crossref","first-page":"eaay5731","DOI":"10.1126\/science.aay5731","article-title":"Aberrant type 1 immunity drives susceptibility to mucosal fungal infections","volume":"371","author":"Break","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.114960_b0550","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/515645","article-title":"Candidiasis in interferon-gamma knockout (IFN-gamma-\/-) mice","volume":"178","author":"Balish","year":"1998","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0555","article-title":"Effects of Boric Acid Gel on Vaginal Candida albicans Infections and the Local Immune System in Mice","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0560","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/INF.0000000000000909","article-title":"Interferon-gamma Immunotherapy in a Patient With Refractory Disseminated Candidiasis","volume":"34","author":"Buddingh","year":"2015","journal-title":"Pediatr. Infect. Dis. J"},{"key":"10.1016\/j.addr.2023.114960_b0565","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/cells9051317","article-title":"TLR2 and Dectin-1 Signaling in Mouse Hematopoietic Stem and Progenitor Cells Impacts the Ability of the Antigen Presenting Cells They Produce to Activate CD4 T Cells","volume":"9","author":"Mart\u00ednez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.addr.2023.114960_b0570","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jinf.2021.12.009","article-title":"T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option","volume":"84","author":"Mellinghoff","year":"2022","journal-title":"J. Infect."},{"key":"10.1016\/j.addr.2023.114960_b0575","doi-asserted-by":"crossref","first-page":"4871","DOI":"10.4049\/jimmunol.1402986","article-title":"IL-33 Enhances Host Tolerance to Candida albicans Kidney Infections through Induction of IL-13 Production by CD4+ T Cells","volume":"194","author":"Tran","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2023.114960_b0580","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"Harrington","year":"2005","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0585","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0590","doi-asserted-by":"crossref","first-page":"e1008115","DOI":"10.1371\/journal.ppat.1008115","article-title":"IL-23 supports host defense against systemic Candida albicans infection by ensuring myeloid cell survival","volume":"15","author":"Nur","year":"2019","journal-title":"PLoS. Pathog"},{"key":"10.1016\/j.addr.2023.114960_b0595","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.addr.2023.114960_b0600","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/422329","article-title":"Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice","volume":"190","author":"Huang","year":"2004","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0605","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chom.2019.02.004","article-title":"Commensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses","volume":"25","author":"Shao","year":"2019","journal-title":"Cell. Host. Microbe"},{"key":"10.1016\/j.addr.2023.114960_b0610","doi-asserted-by":"crossref","first-page":"eabh1209","DOI":"10.1126\/scitranslmed.abh1209","article-title":"CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models","volume":"14","author":"Seif","year":"2022","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.addr.2023.114960_b0615","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.FUNK-0002-2016","article-title":"Antifungal Drugs: The Current Armamentarium and Development of New Agents","volume":"4","author":"Robbins","year":"2016","journal-title":"Microbiol. Spectr"},{"key":"10.1016\/j.addr.2023.114960_b0620","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd.2017.46","article-title":"The antifungal pipeline: a reality check","volume":"16","author":"Perfect","year":"2017","journal-title":"Nature. Reviews. Drug. Discovery"},{"key":"10.1016\/j.addr.2023.114960_b0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12831","article-title":"Mechanisms of echinocandin antifungal drug resistance","volume":"1354","author":"Perlin","year":"2015","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"10.1016\/j.addr.2023.114960_b0630","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2217\/FMB.15.47","article-title":"Medically important fungi respond to azole drugs: an update","volume":"10","author":"Zavrel","year":"2015","journal-title":"Future. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0635","doi-asserted-by":"crossref","first-page":"12429","DOI":"10.1021\/acs.jmedchem.0c00748","article-title":"Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem"},{"key":"10.1016\/j.addr.2023.114960_b0640","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1080\/14756366.2022.2050224","article-title":"Echinocandins - structure, mechanism of action and use in antifungal therapy","volume":"37","author":"Szymanski","year":"2022","journal-title":"J. Enzyme. Inhib. Med. Chem"},{"key":"10.1016\/j.addr.2023.114960_b0645","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0065-3233(01)56011-8","article-title":"Glucan synthase inhibitors as antifungal agents","volume":"56","author":"Kurtz","year":"2001","journal-title":"Adv. Protein. Chem"},{"key":"10.1016\/j.addr.2023.114960_b0650","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","author":"Denning","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2023.114960_b0655","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1128\/AAC.00432-11","article-title":"Discovery of a novel class of orally active antifungal beta-1,3-D-glucan synthase inhibitors","volume":"55","author":"Walker","year":"2011","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0660","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/13543784.2020.1791820","article-title":"Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis","volume":"29","author":"Azie","year":"2020","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.addr.2023.114960_b0665","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41579-022-00796-9","article-title":"Architecture of the dynamic fungal cell wall","volume":"21","author":"Gow","year":"2023","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0670","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1365-2958.2001.02347.x","article-title":"Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity","volume":"39","author":"Munro","year":"2001","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.addr.2023.114960_b0675","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jctb.5030320130","article-title":"Nikkomycins: Microbial inhibitors of chitin synthase","volume":"32","author":"Fiedler","year":"1982","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.addr.2023.114960_b0680","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1128\/jb.176.18.5857-5860.1994","article-title":"Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo","volume":"176","author":"Gaughran","year":"1994","journal-title":"J. Bacteriol"},{"key":"10.1016\/j.addr.2023.114960_b0685","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1128\/AAC.43.6.1401","article-title":"In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole","volume":"43","author":"Li","year":"1999","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0690","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/jac\/dkab052","article-title":"Antifungal activity of nikkomycin Z against Candida auris","volume":"76","author":"Bentz","year":"2021","journal-title":"J. Antimicro. Chemother."},{"key":"10.1016\/j.addr.2023.114960_b0695","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01609-08","article-title":"Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses","volume":"53","author":"Nix","year":"2009","journal-title":"Antimicro. Agents. Chemother."},{"key":"10.1016\/j.addr.2023.114960_b0700","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","author":"Shubitz","year":"2014","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0705","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/21501203.2021.1934176","article-title":"Adhesins in the virulence of opportunistic fungal pathogens of human","volume":"12","author":"Kumari","year":"2021","journal-title":"Mycology"},{"key":"10.1016\/j.addr.2023.114960_b0710","doi-asserted-by":"crossref","unstructured":"E.S. Segal, V. Gritsenko, A. Levitan, B. Yadav, N. Dror, J.L. Steenwyk, Y. Silberberg, K. Mielich, A. Rokas, N.A.R. Gow, R. Kunze, R. Sharan, J. Berman, Gene Essentiality Analyzed by In Vivo Transposon Mutagenesis and Machine Learning in a Stable Haploid Isolate of Candida albicans, mBio, 9 (2018) e02048-18.","DOI":"10.1128\/mBio.02048-18"},{"key":"10.1016\/j.addr.2023.114960_b0715","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1439-0507.2010.01883.x","article-title":"Characterisation of Pga1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation","volume":"54","author":"Hashash","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114960_b0720","doi-asserted-by":"crossref","first-page":"34854","DOI":"10.1038\/srep34854","article-title":"Bst1 is required for Candida albicans infecting host via facilitating cell wall anchorage of Glycosylphosphatidyl inositol anchored proteins","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep"},{"key":"10.1016\/j.addr.2023.114960_b0725","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/EC.00051-14","article-title":"Distinct roles of Candida albicans-specific genes in host-pathogen interactions","volume":"13","author":"Wilson","year":"2014","journal-title":"Eukaryot. Cell"},{"issue":"Pt 3","key":"10.1016\/j.addr.2023.114960_b0730","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj3500815","volume":"350","author":"Kostova","year":"2000","journal-title":"Biochem. J"},{"key":"10.1016\/j.addr.2023.114960_b0735","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1038\/s41467-020-17221-5","article-title":"Jawsamycin exhibits in vivo antifungal properties by inhibiting Spt14\/Gpi3-mediated biosynthesis of glycosylphosphatidylinositol","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b0740","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/AAC.00731-11","article-title":"E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis","volume":"56","author":"Watanabe","year":"2012","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0745","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","author":"Miyazaki","year":"2011","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0750","doi-asserted-by":"crossref","first-page":"e01735","DOI":"10.1128\/AAC.01735-19","article-title":"Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis","volume":"64","author":"Alkhazraji","year":"2020","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0755","doi-asserted-by":"crossref","first-page":"e01713","DOI":"10.1128\/AAC.01713-18","article-title":"APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis","volume":"63","author":"Gebremariam","year":"2019","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0760","first-page":"S526","article-title":"First-in-human study to assess safety, tolerability and pharmacokinetics of APX001 administered by intravenous infusion to healthy subjects, Open Forum","author":"Hodges","year":"2017","journal-title":"Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0765","first-page":"405","article-title":"Biosynthesis and function of GPI proteins in the yeast Saccharomyces cerevisiae","volume":"1771","author":"Pittet","year":"2007","journal-title":"Bba-Mol. Cell. Biol. L."},{"key":"10.1016\/j.addr.2023.114960_b0770","first-page":"115","article-title":"Targeting the GPI biosynthetic pathway, Pathogens and Global","volume":"112","author":"Yadav","year":"2018","journal-title":"Health"},{"key":"10.1016\/j.addr.2023.114960_b0775","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00294-019-00987-7","article-title":"Identification and functional characterization of Candida albicans mannose\u2013ethanolamine phosphotransferase (Mcd4p)","volume":"65","author":"Hasegawa","year":"2019","journal-title":"Current Genetics"},{"key":"10.1016\/j.addr.2023.114960_b0780","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.R700002-JLR200","article-title":"Thematic review series: Lipid Posttranslational Modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids","volume":"48","author":"Peter","year":"2007","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.addr.2023.114960_b0785","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1021\/id5000212","article-title":"Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis","volume":"1","author":"Mann","year":"2015","journal-title":"ACS. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0790","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2958.2011.07961.x","article-title":"Distinct roles of two ceramide synthases, CaLag1p and CaLac1p, in the morphogenesis of Candida albicans","volume":"83","author":"Cheon","year":"2012","journal-title":"Mol. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0795","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1073\/pnas.1009845107","article-title":"Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model","volume":"107","author":"Becker","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.addr.2023.114960_b0800","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12866-015-0588-0","article-title":"Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm","volume":"15","author":"Perdoni","year":"2015","journal-title":"Bmc. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0805","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s004380050969","article-title":"An aureobasidin A resistance gene isolated from Aspergillus is a homolog of yeast AUR1, a gene responsible for inositol phosphorylceramide (IPC) synthase activity","volume":"261","author":"Kuroda","year":"1999","journal-title":"Mol. Gen. Genet"},{"key":"10.1016\/j.addr.2023.114960_b0810","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1371\/journal.ppat.0030092","article-title":"Genome-Wide Fitness Test and Mechanism-of-Action Studies of Inhibitory Compounds in Candida albicans","volume":"3","author":"Xu","year":"2007","journal-title":"PLOS. Pathogens"},{"key":"10.1016\/j.addr.2023.114960_b0815","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.7164\/antibiotics.46.1414","article-title":"Biological properties of aureobasidin A, a cyclic depsipeptide antifungal antibiotic","volume":"46","author":"Takesako","year":"1993","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.addr.2023.114960_b0820","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1074\/jbc.272.15.9809","article-title":"Sphingolipid Synthesis as a Target for Antifungal Drugs","volume":"272","author":"Nagiec","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114960_b0825","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1439-0507.2012.02225.x","article-title":"The inhibitory effects of aureobasidin A on Candida planktonic and biofilm cells","volume":"56","author":"Tan","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.addr.2023.114960_b0830","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.riam.2017.07.001","article-title":"A study on Candida biofilm growth characteristics and its susceptibility to aureobasidin A","volume":"35","author":"Munusamy","year":"2018","journal-title":"Revista. Iberoamericana. de. Micolog\u00eda"},{"key":"10.1016\/j.addr.2023.114960_b0835","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1021\/ja0057272","article-title":"Total Synthesis and Structural Elucidation of Khafrefungin","volume":"123","author":"Wakabayashi","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2023.114960_b0840","doi-asserted-by":"crossref","first-page":"32709","DOI":"10.1074\/jbc.272.51.32709","article-title":"Khafrefungin, a Novel Inhibitor of Sphingolipid Synthesis*","volume":"272","author":"Mandala","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114960_b0845","doi-asserted-by":"crossref","unstructured":"T. Yano, A. Aoyagi, S. Kozuma, Y. Kawamura, I. Tanaka, Y. Suzuki, Y. Takamatsu, T. Takatsu, M. Inukai, Pleofungins, Novel Inositol Phosphorylceramide Synthase Inhibitors, from Phoma sp. SANK 13899, The Journal of Antibiotics, 60 (2007) 136-142.","DOI":"10.1038\/ja.2007.13"},{"key":"10.1016\/j.addr.2023.114960_b0850","first-page":"1383","article-title":"Discovery of Ibomycin, a Complex Macrolactone that Exerts Antifungal Activity by Impeding Endocytic Trafficking and Membrane Function, Cell","volume":"23","author":"Robbins","year":"2016","journal-title":"Chem. Biol"},{"key":"10.1016\/j.addr.2023.114960_b0855","doi-asserted-by":"crossref","first-page":"170075","DOI":"10.1098\/rsob.170075","article-title":"Caryolan-1-ol, an antifungal volatile produced by Streptomyces spp., inhibits the endomembrane system of fungi","volume":"7","author":"Cho","year":"2017","journal-title":"Open. Biol"},{"key":"10.1016\/j.addr.2023.114960_b0860","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.abd6919","article-title":"A marine microbiome antifungal targets urgent-threat drug-resistant fungi","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.114960_b0865","article-title":"Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking","volume":"131","author":"Zhao","year":"2020","journal-title":"J. Clin. Investigat."},{"key":"10.1016\/j.addr.2023.114960_b0870","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1038\/s41467-022-31308-1","article-title":"Targeting fungal membrane homeostasis with imidazopyrazoindoles impairs azole resistance and biofilm formation","volume":"13","author":"Revie","year":"2022","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b0875","doi-asserted-by":"crossref","first-page":"e1000532","DOI":"10.1371\/journal.ppat.1000532","article-title":"Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin","volume":"5","author":"Singh","year":"2009","journal-title":"PLoS. Pathog"},{"key":"10.1016\/j.addr.2023.114960_b0880","doi-asserted-by":"crossref","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","author":"LaFayette","year":"2010","journal-title":"PLoS. Pathog"},{"key":"10.1016\/j.addr.2023.114960_b0885","doi-asserted-by":"crossref","first-page":"e3000358","DOI":"10.1371\/journal.pbio.3000358","article-title":"Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen","volume":"17","author":"O'Meara","year":"2019","journal-title":"PLoS. Biol"},{"key":"10.1016\/j.addr.2023.114960_b0890","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","article-title":"Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus","volume":"10","author":"Whitesell","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b0895","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/acs.jmedchem.9b00826","article-title":"Design and Synthesis of Fungal-Selective Resorcylate Aminopyrazole Hsp90 Inhibitors","volume":"63","author":"Huang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2023.114960_b0900","doi-asserted-by":"crossref","first-page":"e13273","DOI":"10.1111\/cmi.13273","article-title":"Aspergillus fumigatus Hsp90 interacts with the main components of the cell wall integrity pathway and cooperates in heat shock and cell wall stress adaptation","volume":"23","author":"Rocha","year":"2021","journal-title":"Cell. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b0905","doi-asserted-by":"crossref","first-page":"e0005836","DOI":"10.1371\/journal.pntd.0005836","article-title":"Heat shock protein 90 localizes to the surface and augments virulence factors of Cryptococcus neoformans","volume":"11","author":"Chatterjee","year":"2017","journal-title":"PLoS. Negl. Trop. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0910","first-page":"86","article-title":"Isolation and partial characterization of Hsp90 from Candida albicans","volume":"33","author":"Burt","year":"2003","journal-title":"Ann. Clin. Lab. Sci"},{"key":"10.1016\/j.addr.2023.114960_b0915","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(88)92547-0","article-title":"Candida and AIDS: evidence for protective antibody","volume":"2","author":"Matthews","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2023.114960_b0920","first-page":"20","article-title":"Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis","volume":"74","author":"Matthews","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2023.114960_b0925","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02931297","article-title":"Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis","volume":"50","author":"Raska","year":"2005","journal-title":"Folia. Microbiol. (Praha)"},{"key":"10.1016\/j.addr.2023.114960_b0930","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijbiomac.2021.01.105","article-title":"Chitosan hydrogel loaded with recombinant protein containing epitope C from HSP90 of Candida albicans induces protective immune responses against systemic candidiasis","volume":"173","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol"},{"key":"10.1016\/j.addr.2023.114960_b0935","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s11095-014-1516-y","article-title":"Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP\/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity","volume":"32","author":"Knotigova","year":"2015","journal-title":"Pharm. Res"},{"key":"10.1016\/j.addr.2023.114960_b0940","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1016\/j.vaccine.2006.05.022","article-title":"Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL\/6J mice","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2023.114960_b0945","article-title":"Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis","author":"Bugli","year":"2013","journal-title":"Clin. Devel. Immunol. 2013"},{"key":"10.1016\/j.addr.2023.114960_b0950","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0955","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2004.08.013","article-title":"Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time-kill methodologies","volume":"51","author":"Nooney","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0960","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/503428","article-title":"A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis","volume":"42","author":"Pachl","year":"2006","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b0965","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.inf.0000237922.28863.ab","article-title":"Human recombinant antibody against Candida","volume":"25","author":"Rowlands","year":"2006","journal-title":"Pediatr. Infect. Dis. J"},{"key":"10.1016\/j.addr.2023.114960_b0970","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1097\/PCC.0b013e31817286e8","article-title":"Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole","volume":"9","author":"Sutherland","year":"2008","journal-title":"Pediatr. Crit. Care. Med"},{"key":"10.1016\/j.addr.2023.114960_b0975","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1128\/AAC.01324-10","article-title":"Dose range evaluation of Mycograb C28Y variant, a human recombinant antibody fragment to heat shock protein 90, in combination with amphotericin B-desoxycholate for treatment of murine systemic candidiasis","volume":"55","author":"Louie","year":"2011","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0980","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/21505594.2016.1188235","article-title":"Exploiting mitochondria as targets for the development of new antifungals","volume":"8","author":"Li","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.addr.2023.114960_b0985","doi-asserted-by":"crossref","first-page":"e00374","DOI":"10.1128\/AAC.00374-19","article-title":"The Novel Arylamidine T-2307 Selectively Disrupts Yeast Mitochondrial Function by Inhibiting Respiratory Chain Complexes","volume":"63","author":"Yamashita","year":"2019","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0990","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.01159-07","article-title":"In vitro and in vivo antifungal activities of T-2307, a novel arylamidine","volume":"52","author":"Mitsuyama","year":"2008","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b0995","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.05954-11","article-title":"T-2307 causes collapse of mitochondrial membrane potential in yeast","volume":"56","author":"Shibata","year":"2012","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b1000","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1074\/jbc.M808914200","article-title":"Ilicicolin Inhibition and Binding at Center N of the Dimeric Cytochrome bc1 Complex Reveal Electron Transfer and Regulatory Interactions between Monomers","volume":"284","author":"Covian","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.addr.2023.114960_b1005","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/ml300173e","article-title":"Antifungal spectrum, in vivo efficacy, and structure-activity relationship of ilicicolin h","volume":"3","author":"Singh","year":"2012","journal-title":"ACS. Med. Chem. Lett"},{"key":"10.1016\/j.addr.2023.114960_b1010","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1016\/j.bmcl.2013.03.023","article-title":"Structure-activity relationship of cytochrome bc1 reductase inhibitor broad spectrum antifungal ilicicolin H","volume":"23","author":"Singh","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.addr.2023.114960_b1015","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2021.126786","article-title":"Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target","volume":"249","author":"Li","year":"2021","journal-title":"Microbiol. Res"},{"key":"10.1016\/j.addr.2023.114960_b1020","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1128\/AAC.47.3.956-964.2003","article-title":"Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei","volume":"47","author":"Onyewu","year":"2003","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b1025","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1038\/s41467-019-12199-1","article-title":"Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents","volume":"10","author":"Juvvadi","year":"2019","journal-title":"Nat. Commun"},{"key":"10.1016\/j.addr.2023.114960_b1030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol"},{"key":"10.1016\/j.addr.2023.114960_b1035","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/fmb-2019-0343","article-title":"Histone acetylation\/deacetylation in Candida albicans and their potential as antifungal targets","volume":"15","author":"Su","year":"2020","journal-title":"Future. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b1040","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.celrep.2012.08.035","article-title":"Lysine deacetylases Hda1 and Rpd3 regulate Hsp90 function thereby governing fungal drug resistance","volume":"2","author":"Robbins","year":"2012","journal-title":"Cell. Rep"},{"key":"10.1016\/j.addr.2023.114960_b1045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.12688\/f1000research.2-238.v1","article-title":"Functional characterization of Candida albicans Hos2 histone deacetylase","volume":"2","author":"Karthikeyan","year":"2013","journal-title":"F1000Res"},{"key":"10.1016\/j.addr.2023.114960_b1050","doi-asserted-by":"crossref","first-page":"e1000889","DOI":"10.1371\/journal.ppat.1000889","article-title":"The Set3\/Hos2 Histone Deacetylase Complex Attenuates cAMP\/PKA Signaling to Regulate Morphogenesis and Virulence of Candida albicans","volume":"6","author":"Hnisz","year":"2010","journal-title":"PLOS. Pathogens"},{"key":"10.1016\/j.addr.2023.114960_b1055","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.680732","article-title":"Candida albicans SET3 Plays a Role in Early Biofilm Formation, Interaction With Pseudomonas aeruginosa and Virulence in Caenorhabditis elegans","volume":"11","author":"Fourie","year":"2021","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b1060","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, Combination with Azole Antifungals against Opportunistic Fungal Pathogens","volume":"47","author":"Pfaller","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.addr.2023.114960_b1065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2014.11.008","article-title":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","volume":"81","author":"Pfaller","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis"},{"key":"10.1016\/j.addr.2023.114960_b1070","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/gb-2010-11-7-r77","article-title":"Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering","volume":"11","author":"Kuo","year":"2010","journal-title":"Genome. Biol"},{"key":"10.1016\/j.addr.2023.114960_b1075","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1159746","article-title":"Outwitting multidrug resistance to antifungals","volume":"321","author":"Monk","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.addr.2023.114960_b1080","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1128\/AAC.00926-08","article-title":"Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance","volume":"53","author":"Tsao","year":"2009","journal-title":"Antimicrob. Agents. Chemother"},{"key":"10.1016\/j.addr.2023.114960_b1085","doi-asserted-by":"crossref","first-page":"e0032121","DOI":"10.1128\/Spectrum.00321-21","article-title":"Multifactorial Mechanisms of Tolerance to Ketoconazole in Candida albicans","volume":"9","author":"Xu","year":"2021","journal-title":"Microbiol. Spectr"},{"key":"10.1016\/j.addr.2023.114960_b1090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biochi.2019.12.002","article-title":"Deletion of CDR1 reveals redox regulation of pleiotropic drug resistance in Candida glabrata","volume":"170","author":"Galkina","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.addr.2023.114960_b1095","doi-asserted-by":"crossref","first-page":"e03333","DOI":"10.1128\/mBio.03333-20","article-title":"Genome-Wide Analysis of Experimentally Evolved Candida auris Reveals Multiple Novel Mechanisms of Multidrug Resistance","volume":"12","author":"Carolus","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.addr.2023.114960_b1100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/jof7090760","article-title":"Participation of the ABC Transporter CDR1 in Azole Resistance of Candida lusitaniae","volume":"7","author":"Borgeat","year":"2021","journal-title":"J. Fungi. (Basel)"},{"key":"10.1016\/j.addr.2023.114960_b1105","first-page":"27","article-title":"Flavonols, and Glycosylated Derivatives-Impact on Candida albicans Growth and Virulence, Expression of CDR1 and ERG11, Cytotoxicity, Pharmaceuticals","volume":"14","author":"Ivanov","year":"2021","journal-title":"(Basel)"},{"key":"10.1016\/j.addr.2023.114960_b1110","first-page":"1436","article-title":"Revealing the astragalin mode of anticandidal action","volume":"19","author":"Ivanov","year":"2020","journal-title":"EXCLI. J"},{"key":"10.1016\/j.addr.2023.114960_b1115","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3109\/13880209.2015.1091483","article-title":"The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans","volume":"54","author":"Shao","year":"2016","journal-title":"Pharm. Biol"},{"key":"10.1016\/j.addr.2023.114960_b1120","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3389\/fmicb.2020.01498","article-title":"Synergistic Effect of Berberine Hydrochloride and Fluconazole Against Candida albicans Resistant Isolates","volume":"11","author":"Yong","year":"2020","journal-title":"Front. Microbiol"},{"key":"10.1016\/j.addr.2023.114960_b1125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature16963","article-title":"Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction","volume":"530","author":"Nishikawa","year":"2016","journal-title":"Nature"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23002752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:41:36Z","timestamp":1759210896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23002752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":225,"alternative-id":["S0169409X23002752"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114960","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114960"}}